Ci Investments Inc. Amgen Inc Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Amgen Inc stock. As of the latest transaction made, Ci Investments Inc. holds 55,075 shares of AMGN stock, worth $15.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

55,075

Previous 55,210 0.24%

Holding current value

$15.9 Million

Previous $17.3 Million 2.88%

% of portfolio

0.07%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $41,766 - $45,546	-135 Reduced 0.24%	55,075 $17.7 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $2.05 Million - $2.49 Million	-7,803 Reduced 12.38%	55,210 $17.3 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $2.96 Million - $3.57 Million	11,006 Added 21.16%	63,013 $17.9 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $1.76 Million - $1.99 Million	-6,890 Reduced 11.7%	52,007 $15 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $338,907 - $420,762	-1,550 Reduced 2.56%	58,897 $15.8 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $406,470 - $480,642	-1,897 Reduced 3.04%	60,447 $13.4 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $3.39 Million - $4.13 Million	15,001 Added 31.69%	62,344 $15.1 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $1.15 Million - $1.46 Million	-5,006 Reduced 9.56%	47,343 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $259,251 - $292,388	1,155 Added 2.26%	52,349 $11.8 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $978,441 - $1.09 Million	-4,241 Reduced 7.65%	51,194 $12.5 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $1.24 Million - $1.38 Million	5,677 Added 11.41%	55,435 $13.4 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $1.51 Million - $1.72 Million	7,571 Added 17.95%	49,758 $11.2 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $2.3 Million - $2.7 Million	-10,858 Reduced 20.47%	42,187 $8.97 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $12,146 - $13,475	-52 Reduced 0.1%	53,045 $12.9 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $1.9 Million - $2.21 Million	-8,562 Reduced 13.89%	53,097 $13.2 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $4.23 Million - $5.04 Million	19,566 Added 46.48%	61,659 $14.2 Million
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $1.54 Million - $1.71 Million	6,551 Added 18.43%	42,093 $10.7 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $1.51 Million - $1.85 Million	-7,609 Reduced 17.63%	35,542 $8.38 Million
Q1 2020 Aug 07, 2020	SELL	$182.24 - $241.7 $59.7 Million - $79.2 Million	-327,672 Reduced 88.36%	43,151 $8.75 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $63.1 Million - $81.1 Million	333,372 Added 890.16%	370,823 $89.4 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $6.52 Million - $7.81 Million	37,451 New	37,451 $7.25 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $399,579 - $468,397	-2,397 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $264,070 - $297,664	-1,460 Reduced 37.85%	2,397 $455,000
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $688,088 - $803,220	3,857 New	3,857 $750,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $6.42 Million - $7.5 Million	-37,898 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $1.77 Million - $1.98 Million	-10,491 Reduced 21.68%	37,898 $6.59 Million
Q3 2017 May 11, 2018	SELL	$167.29 - $191.0 $13.2 Million - $15 Million	-78,650 Reduced 61.91%	48,389 $9.02 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $21.3 Million - $24.3 Million	127,039	127,039 $23.7 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Amgen Inc Transaction History